| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/03/2008 | EP1963319A1 Heteroarylpyrrolopyridinones active as kinase inhibitors |
| 09/03/2008 | EP1963318A1 Pyrrolo[2,3-c]pyridine derivatives |
| 09/03/2008 | EP1963317A1 Use of pyrrolo [2 , 3-b]pyridines to prepare a medicament for treating pain |
| 09/03/2008 | EP1963316A2 Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors |
| 09/03/2008 | EP1963315A2 Enzyme inhibitors |
| 09/03/2008 | EP1963314A2 P38 kinase inhibiting agents |
| 09/03/2008 | EP1963313A2 Inhibitors of diacylglycerol acyltransferase (dgat) |
| 09/03/2008 | EP1963312A1 Beta-secretase modulators and methods of use |
| 09/03/2008 | EP1963311A1 Chromane substituted benzimidazoles and their use as acid pump inhibitors |
| 09/03/2008 | EP1963310A2 Methods of preparing a vegf-r inhibitor |
| 09/03/2008 | EP1963307A1 3- (4- { [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl[0xy] phenyl) -1-piperidinyl carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders |
| 09/03/2008 | EP1963306A2 Esomeprazole arginine |
| 09/03/2008 | EP1963303A2 Chemical compounds |
| 09/03/2008 | EP1963302A2 Polymorphs of a c-met/hgfr inhibitor |
| 09/03/2008 | EP1963300A1 Benzochromene derivatives for use in liquid crystal media and as therapeutic active substances |
| 09/03/2008 | EP1963295A1 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazine derivatives |
| 09/03/2008 | EP1963294A1 1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (ptpase) |
| 09/03/2008 | EP1963293A1 1-orthofluorophenyl substituted 1, 2 , 5-thiazolidinedione derivatives as ptp-as inhibitors |
| 09/03/2008 | EP1963292A2 Organic compounds |
| 09/03/2008 | EP1963289A1 Substituted oxadiazole derivatives and their use as opioid receptor ligands |
| 09/03/2008 | EP1963288A1 Substituted oxazole derivatives with an analgesic action |
| 09/03/2008 | EP1963287A1 Glucocorticoid receptor modulators as antiinflammatory agents |
| 09/03/2008 | EP1963285A1 Bradykinin 1 receptor antagonists |
| 09/03/2008 | EP1963283A2 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 09/03/2008 | EP1963282A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 09/03/2008 | EP1963281A2 Heterocyclic derivatives as modulators of ion channels |
| 09/03/2008 | EP1963280A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 09/03/2008 | EP1963279A1 Derivatives of 2-nitro-1,3-imidazole coupled to amino acids and deoxyribose useful for the detection of hypoxic biological tissue |
| 09/03/2008 | EP1963278A1 Substituted imidazoline derivatives |
| 09/03/2008 | EP1963277A1 Fluorinated compounds |
| 09/03/2008 | EP1963276A1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation |
| 09/03/2008 | EP1963275A2 P2x7 receptor antagonists and uses thereof |
| 09/03/2008 | EP1963272A1 Hydroxyquinoline derivatives |
| 09/03/2008 | EP1963271A1 Quinolone m1 receptor positive allosteric modulators |
| 09/03/2008 | EP1963270A1 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents |
| 09/03/2008 | EP1963264A2 New 3 -, 7-substituted indirubins and their applications |
| 09/03/2008 | EP1963263A1 POLYMORPHS OF [R-(R*, R*)]-2-(4-FLUOROPHENYL)- BETA,DELTA -DIHYDROXY-5-(L-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-lH-PYRROLE-l-HEPTANOIC ACID MAGNESIUM SALT (2: 1) |
| 09/03/2008 | EP1963261A1 Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation |
| 09/03/2008 | EP1963259A2 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |
| 09/03/2008 | EP1963258A2 Histone deacetylase inhibitors for enhancing activity of antifungal agents |
| 09/03/2008 | EP1963255A1 Synephrine derivatives useful as anti-inflammatory agents |
| 09/03/2008 | EP1963250A1 Biphenyl derivatives as selective agonists of gamma rar receptor |
| 09/03/2008 | EP1963249A1 Biphenyl derivatives as selective agonists of gamma rar receptors |
| 09/03/2008 | EP1962960A1 Micronization method |
| 09/03/2008 | EP1962909A2 Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo tm) contiaining different lengths of palindromic segments |
| 09/03/2008 | EP1962878A2 Formulation and methods for use of morinda citrifolia seed oil |
| 09/03/2008 | EP1962875A2 In vitro and in vivo anti-inflammatory effects of a sesquiterpene lactone extract from chicory (cichorium intybus l.) |
| 09/03/2008 | EP1962869A1 Treatment of respiratory diseases |
| 09/03/2008 | EP1962868A2 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
| 09/03/2008 | EP1962867A2 Biocompatible surgical compositions |
| 09/03/2008 | EP1962866A2 Hydrophobic elastomeric polymer chemistry device for inhibiting the growth of onychomycosis and urushiol-induced allergic contact dermatitis |
| 09/03/2008 | EP1962865A1 Anti-gastritis and anti-ulcer agent containing momordicae semen extract and momordica saponin i isolated from the same |
| 09/03/2008 | EP1962864A1 Antibacterial agents |
| 09/03/2008 | EP1962863A2 Orally active purine-based inhibitors of heat shock protein 90 |
| 09/03/2008 | EP1962862A2 Alkyl phospholipid derivatives with reduced cytotoxicity and uses therof |
| 09/03/2008 | EP1962861A2 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 09/03/2008 | EP1962860A1 Methods of treating gastrointestinal tract infections with tigecycline |
| 09/03/2008 | EP1962859A1 Vitamin d derivatives for the treatment of type i diabetes |
| 09/03/2008 | EP1962858A1 Phytosterols for use in reducing c-reactive protein levels |
| 09/03/2008 | EP1962857A2 Use of anecortave acetate as an adjunct during filtration bleb surgery |
| 09/03/2008 | EP1962856A2 Medicament based on a monoester of steroids with long chain fatty acids |
| 09/03/2008 | EP1962855A2 Trpa1 inhibitors for treating pain |
| 09/03/2008 | EP1962854A2 Pyridopyrazine derivatives and use thereof as modulators of the signal transduction paths |
| 09/03/2008 | EP1962853A1 (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions |
| 09/03/2008 | EP1962851A2 Compounds |
| 09/03/2008 | EP1962850A1 Treatment of drug-resistant tumors |
| 09/03/2008 | EP1962849A1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 09/03/2008 | EP1962848A2 Combinations of indacaterol derivatives and other agents for the treatment of airway diseases |
| 09/03/2008 | EP1962847A2 Pyridinyl sulfonamide modulators of chemokine receptors |
| 09/03/2008 | EP1962846A2 Certain chemical entities, compositions, and methods |
| 09/03/2008 | EP1962845A2 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 09/03/2008 | EP1962844A2 Lansoprazole orally disintegrating tablets |
| 09/03/2008 | EP1962843A2 Use of parp-1 inhibitors |
| 09/03/2008 | EP1962842A1 Diaryl ureas for treating inflammatory skin, eye and/or ear diseases |
| 09/03/2008 | EP1962841A1 Diaryl urea for treating virus infections |
| 09/03/2008 | EP1962840A1 Use of 4, 7-dihydrothieno [2, 3-b]pyridine compounds in the treatment of cardiovascular diseases |
| 09/03/2008 | EP1962839A2 Administration of mntor inhibitor to treat patients with cancer |
| 09/03/2008 | EP1962838A2 Farnesoid x receptor agonists |
| 09/03/2008 | EP1962836A2 Treatment of length dependent neuropathy |
| 09/03/2008 | EP1962835A2 Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and/or h3 receptor antagonist/inverse agonist |
| 09/03/2008 | EP1962834A2 Use of a cb1 antagonist for treating negative symptoms of schizophrenia |
| 09/03/2008 | EP1962833A2 Photoactivatable antimicrobial agents |
| 09/03/2008 | EP1962832A2 Combinations of a qualene synthase inhibitor and a hmg-coa reductase inhibitor for treating hyperlipidemia |
| 09/03/2008 | EP1962831A2 Modified and pulsatile release pharmaceutical formulations of escitalopram |
| 09/03/2008 | EP1962830A2 Azaindole inhibitors of aurora kinases |
| 09/03/2008 | EP1962829A1 Diaryl ureas for treating virus infections |
| 09/03/2008 | EP1962828A1 Diaryl urea for treating inflammatory skin, eye and/or ear diseases |
| 09/03/2008 | EP1962827A2 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 09/03/2008 | EP1962826A2 Method for weight reduction |
| 09/03/2008 | EP1962825A2 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage |
| 09/03/2008 | EP1962824A1 Methods for reducing the amount of proinflammatory substance in animal tissue or body fluid |
| 09/03/2008 | EP1962823A2 Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
| 09/03/2008 | EP1962822A1 Therapy of malignant neoplasias |
| 09/03/2008 | EP1962821A1 Transdermal administration of active agents , in particular diclofenac |
| 09/03/2008 | EP1962820A2 Medicament for the treatment of impaired glucose metabolism |
| 09/03/2008 | EP1962819A1 Control of cci-779 dosage form stability through control of drug substance impurities |
| 09/03/2008 | EP1962818A1 Use of a dermatological composition comprising an association of hydroquinone, fluocinolone acetonide and tretinoin for treating skin hyperpigmentation following psoriasis or eczema |
| 09/03/2008 | EP1962817A2 Transdermal delivery of meptazinol |
| 09/03/2008 | EP1962811A2 Solid preparation containing an insulin sensitizer |
| 09/03/2008 | EP1962808A2 Hcv prodrug formulation |